cbdMD, Inc. YCBD

Set alert

Price alert · YCBD

All alert types
0.42 USD +0.02 +5.87%

As of Nov 3, 11:13 AM ET

Bid
0.40 × 2,000
Ask
0.48 × 100
0.385 Day range 0.455
0.33 52-week range 2.56
YTD
-68.89%
1 year
-50.06%
Open
0.391
Prev close
0.3967
Mkt cap
4.71M
Vol
192.93K
Avg vol
390.84K
EPS
0.23
P/E
1.83
Div yield
0.00%
More statistics
Low
0.385
High
0.455
Forward P/E
-0.38
Beta
1.99
Short ratio
1.14
Inst. own
3.33%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2025
50-d avg
0.46466
200-d avg
0.61418
1y target
2.00

15m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (49)
NameTimeAgo
SMA: BearishNov 2, 4:00 PM19 hours ago
MACD: Sell SignalNov 2, 4:00 PM19 hours ago
MACD: Buy SignalNov 2, 3:55 PM19 hours ago
SMA: BullishNov 2, 3:30 PM19 hours ago
SMA: BullishNov 2, 3:10 PM20 hours ago
SMA: BearishNov 2, 2:55 PM20 hours ago
SMA: BearishNov 2, 2:55 PM20 hours ago
MACD: Sell SignalNov 2, 2:55 PM20 hours ago
SMA: BullishNov 2, 2:00 PM21 hours ago
SMA: BullishNov 2, 1:15 PM21 hours ago
SMA: BearishNov 2, 12:55 PM22 hours ago
SMA: BearishNov 2, 12:55 PM22 hours ago
SMA: BullishNov 2, 12:20 PM22 hours ago
SMA: BullishNov 2, 12:20 PM22 hours ago
SMA: BearishNov 2, 11:55 AM23 hours ago
SMA: BearishNov 2, 11:55 AM23 hours ago
SMA: BullishNov 2, 11:05 AM1 day ago
MACD: Buy SignalNov 2, 11:05 AM1 day ago
SMA: BullishNov 2, 10:40 AM1 day ago
SMA: BearishNov 2, 9:55 AM1 day ago

Newest 20 of 49.

Key statistics

Market cap
1.53M
Enterprise value
3.22M
Trailing P/E
0.00
Forward P/E
-0.38
PEG ratio
0.00
Price / sales
0.07
Price / book
0.43
EPS (TTM)
-1.79
Beta
1.99
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-94.12%
Revenue (TTM)
20.64M
Revenue growth
-15.50%
Free cash flow
4.69M
Total cash
2.40M
Total debt
4.11M
Return on equity
-135.07%
Shares outstanding
4.47M
Short % of float
4.74%
50-day average
0.46466
200-day average
0.61418

Analyst view

Consensus: none

Price target (mean) 2.00

Next earnings

Feb 11, 2025

Expected Feb 11, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
YCBD Revenue — quarterly 5.55M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
YCBD Net income — quarterly -1.13M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
YCBD EPS — quarterly -0.11
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026

Earnings

YCBD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 11, 2025Dec 1, 20240.00———
Dec 17, 2024Sep 1, 20240.00———
Aug 14, 2024Jun 1, 20240.00-0.15——
May 15, 2024Mar 1, 20240.00-1.35——
Feb 13, 2024Dec 1, 20230.00-0.67——
Dec 22, 2023Sep 1, 20230.00-9.06——

Upgrades / downgrades

YCBD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 5, 2023Maxim Groupinit—Buy

About cbdMD, Inc.

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
cbdmd.com

News

Your note

Sign in to keep a note on YCBD — it syncs with the Stock Master app.

Insider holders

YCBD insider holders
InsiderRelationLatest transactionDateShares held
COFFMAN RAYMOND SCOTTBeneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Jan 10, 20240
KENNEDY THOMAS RONANChief Executive OfficerPurchaseMay 2, 20236,462
RAINES WILLIAM F IIIDirectorStock Award(Grant)Aug 22, 202484,256
SELLERS BAKARI TDirectorStock Award(Grant)Mar 27, 20249,438
STEPHEN SCOTT GDirectorStock Award(Grant)Mar 27, 202410,138
SWIFT SIBYL NICHOLEDirectorStock Award(Grant)Mar 27, 20248,008

Institution ownership

YCBD institution ownership
Holder% heldSharesValueReported
Connective Capital Management LLC1.61%89,21530.53KSep 29, 2024
Two Sigma Securities, LLC0.40%22,0667.55KSep 29, 2024
Vanguard Group Inc0.24%13,0424.46KSep 29, 2024
Geode Capital Management, LLC0.20%11,1953.83KSep 29, 2024
Blackrock Inc.0.16%8,9053.05KSep 29, 2024
UBS Group AG0.06%3,1761.09KSep 29, 2024

Fund ownership

YCBD fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.24%13,0424.46KSep 29, 2024
Fidelity Extended Market Index Fund0.16%8,9923.08KOct 30, 2024
Fidelity Total Market Index Fund0.02%1,124384Oct 30, 2024
Fidelity Series Total Market Index Fund0.02%1,079369Oct 30, 2024